down arrow

Caplin Point Lab

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE475E01026
  • NSEID: CAPLIPOINT
  • BSEID: 524742
INR
1,829.95
114.95 (6.7%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 2.98 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

1,754.851,868.00

52 Week

1,221.002,636.00
Valuation
Technical
Day's Volume

CASH

2.98 lacs (164.75%) Volume

Shareholding (Dec 2024)

FII

4.86%

Held by 126 FIIs

DII

2.11%

Held by 5 DIIs

Promoter

70.56%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Poor long term growth as Operating profit has grown by an annual rate 18.31% of over the last 5 years

 
2

Stock is technically in a Mildly Bearish range

3

With ROE of 19.4, it has a Very Expensive valuation with a 5.1 Price to Book Value

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 13,910 Cr (Mid Cap)

stock-summary
P/E

25.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.29%

stock-summary
Debt Equity

-0.32

stock-summary
Return on Equity

19.41%

stock-summary
Price to Book

5.13

Revenue and Profits (1 Year):
Net Sales:
493 Cr
(Quarterly Results - Dec 2024)
Net Profit:
139 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.29%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-4.08%
0%
-4.08%
1 Year
39.21%
0.38%
39.59%
2 Years
188.61%
1.39%
190.0%
3 Years
136.44%
2.04%
138.48%
4 Years
287.13%
2.62%
289.75%
5 Years
530.91%
5.26%
536.17%

Latest dividend: 2.5 per share ex-dividend date: Sep-23-2024

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
17.72%
EBIT Growth (5y)
18.31%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.82
Tax Ratio
19.98%
Dividend Payout Ratio
8.31%
Pledged Shares
0
Institutional Holding
6.97%
ROCE (avg)
35.07%
ROE (avg)
20.15%
Valuation key factors
Factor
Value
P/E Ratio
25
Industry P/E
33
Price to Book Value
5.13
EV to EBIT
21.85
EV to EBITDA
19.57
EV to Capital Employed
7.11
EV to Sales
6.47
PEG Ratio
1.43
Dividend Yield
0.29%
ROCE (Latest)
31.49%
ROE (Latest)
19.41%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 16 Schemes (1.86%)

FIIs

Held by 126 FIIs (4.86%)

Promoter with highest holding

P Vijayalakshmi (24.71%)

Highest Public shareholder

Uti Small Cap Fund (1.39%)

Individual Investors Holdings

15.77%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 13.19% vs 17.05% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 18.57% vs 20.23% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "492.96",
          "val2": "435.50",
          "chgp": "13.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "162.29",
          "val2": "142.28",
          "chgp": "14.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.18",
          "val2": "0.17",
          "chgp": "5.88%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "138.96",
          "val2": "117.20",
          "chgp": "18.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "32.92%",
          "val2": "32.67%",
          "chgp": "0.25%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 16.97% vs 14.18% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 16.71% vs 23.57% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "942.06",
          "val2": "805.38",
          "chgp": "16.97%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "316.57",
          "val2": "263.93",
          "chgp": "19.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.26",
          "val2": "0.46",
          "chgp": "-43.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "254.77",
          "val2": "218.30",
          "chgp": "16.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "33.60%",
          "val2": "32.77%",
          "chgp": "0.83%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 15.65% vs 15.17% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 17.36% vs 22.38% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,435.02",
          "val2": "1,240.88",
          "chgp": "15.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "478.86",
          "val2": "406.21",
          "chgp": "17.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.44",
          "val2": "0.63",
          "chgp": "-30.16%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "393.73",
          "val2": "335.50",
          "chgp": "17.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "33.37%",
          "val2": "32.74%",
          "chgp": "0.63%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 15.50% vs 15.54% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 21.48% vs 25.49% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,694.10",
          "val2": "1,466.73",
          "chgp": "15.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "551.44",
          "val2": "441.06",
          "chgp": "25.03%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.78",
          "val2": "0.78",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "457.09",
          "val2": "376.26",
          "chgp": "21.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "32.55%",
          "val2": "30.07%",
          "chgp": "2.48%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - YoYstock-summary
Dec'24
Dec'23
Change(%)
Net Sales
492.96
435.50
13.19%
Operating Profit (PBDIT) excl Other Income
162.29
142.28
14.06%
Interest
0.18
0.17
5.88%
Exceptional Items
0.00
0.00
Consolidate Net Profit
138.96
117.20
18.57%
Operating Profit Margin (Excl OI)
32.92%
32.67%
0.25%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2024 is 13.19% vs 17.05% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2024 is 18.57% vs 20.23% in Dec 2023

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
942.06
805.38
16.97%
Operating Profit (PBDIT) excl Other Income
316.57
263.93
19.94%
Interest
0.26
0.46
-43.48%
Exceptional Items
0.00
0.00
Consolidate Net Profit
254.77
218.30
16.71%
Operating Profit Margin (Excl OI)
33.60%
32.77%
0.83%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 16.97% vs 14.18% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 16.71% vs 23.57% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
1,435.02
1,240.88
15.65%
Operating Profit (PBDIT) excl Other Income
478.86
406.21
17.88%
Interest
0.44
0.63
-30.16%
Exceptional Items
0.00
0.00
Consolidate Net Profit
393.73
335.50
17.36%
Operating Profit Margin (Excl OI)
33.37%
32.74%
0.63%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 15.65% vs 15.17% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 17.36% vs 22.38% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
1,694.10
1,466.73
15.50%
Operating Profit (PBDIT) excl Other Income
551.44
441.06
25.03%
Interest
0.78
0.78
Exceptional Items
0.00
0.00
Consolidate Net Profit
457.09
376.26
21.48%
Operating Profit Margin (Excl OI)
32.55%
30.07%
2.48%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 15.50% vs 15.54% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 21.48% vs 25.49% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Caplin Point Laboratories Ltd stock-summary
stock-summary
Caplin Point Laboratories Ltd
Mid Cap
Pharmaceuticals & Drugs
Promoted by Mr. C. C. Paarthipan, Caplin Point Laboratories Limited was incorporated on April 16th, 1990. The Company is a fully integrated Pharma Company and is presently into the business of pharmaceuticals like producing, developing and marketing wide range of generic formulations and branded products and exporting to overseas market. Its main research and development facilities are located in Tamil Nadu, India and has a manufacturing plant in Puducherry, India.
Company Coordinates stock-summary
Company Details
Ashvich Towers 3rd Floor, No 3 Developed Plots Ind Estat Chennai Tamil Nadu : 600096
stock-summary
Tel: 91-44-24968000/71148000/28156653
stock-summary
http://www.caplinpoint.net
stock-summary
investor@caplinpoint.net/info@capli
Registrar Details
Integrated Enterprises (India) Ltd , II Floor , Kences Towers, No 1 Ramakrishna Street, North Usman Road, T Nagar, Chennai
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."